Growth Metrics

CorMedix (CRMD) Cash from Operations (2016 - 2025)

CorMedix (CRMD) has disclosed Cash from Operations for 13 consecutive years, with 94461181.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 1782.34% to 94461181.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 175046000.0 through Dec 2025, up 445.84% year-over-year, with the annual reading at 175046000.0 for FY2025, 445.84% up from the prior year.
  • Cash from Operations hit 94461181.0 in Q4 2025 for CorMedix, up from 30856502.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 94461181.0 in Q4 2025 to a low of 17310294.0 in Q1 2024.
  • Historically, Cash from Operations has averaged 4030891.71 across 5 years, with a median of 5869360.0 in 2021.
  • Biggest five-year swings in Cash from Operations: crashed 309.81% in 2021 and later skyrocketed 1782.34% in 2025.
  • Year by year, Cash from Operations stood at 5869360.0 in 2021, then dropped by 4.86% to 6154839.0 in 2022, then plummeted by 68.87% to 10393886.0 in 2023, then skyrocketed by 45.98% to 5614883.0 in 2024, then surged by 1782.34% to 94461181.0 in 2025.
  • Business Quant data shows Cash from Operations for CRMD at 94461181.0 in Q4 2025, 30856502.0 in Q3 2025, and 29991814.0 in Q2 2025.